This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Technical University of Darmstadt, Trinity College Dublin. Active years: 2013.
Company Filing History:
1 out of 1,333 
1 out of 37 
1 out of 141 
Years Active: 2013
Title: The Innovations of Markus Pickhardt
Introduction
Markus Pickhardt is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. His work has garnered attention for its potential impact on medical science.
Latest Patents
One of Markus Pickhardt's key patents is titled "Thiazolhydrazides for treatment of neurodegenerative diseases." This patent describes compounds that feature a thiazolhydrazide scaffold, along with pharmaceutically acceptable salts and compositions. These compounds can be utilized for the prophylaxis and treatment of various neurodegenerative diseases and conditions.
Career Highlights
Throughout his career, Markus Pickhardt has worked with esteemed institutions such as the Max Planck Society for the Advancement of Science and Technische Universität Darmstadt. His experience in these organizations has contributed to his expertise in the field of neurodegenerative research.
Collaborations
Markus has collaborated with notable colleagues, including Eckhard Mandelkow and Eva-Maria Mandelkow. Their joint efforts have furthered research in neurodegenerative diseases and have led to advancements in therapeutic approaches.
Conclusion
Markus Pickhardt's innovative work in the pharmaceutical field, particularly with thiazolhydrazides, showcases his commitment to addressing neurodegenerative diseases. His contributions are paving the way for future advancements in medical treatments.